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Melatonin induces antiproliferative activity through modulation of apoptotic
pathway in H-ras oncogene transformed 5RP7 cells
1

2,

1

Ayşe KAPLAN , Gülşen AKALIN ÇİFTÇİ *, Hatice Mehtap KUTLU
Department of Biology, Faculty of Science, Anadolu University, Eskişehir, Turkey
2
Department of Biochemistry, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey
1

Received: 28..04.2015

Accepted/Published Online: 07.07.2015

Printed: 31.12.2015

Abstract: In the present study, cytotoxic and apoptotic effects of melatonin were investigated on H-ras oncogene transformed rat embryo
fibroblast 5RP7 cells. Melatonin inhibited cell growth and induced apoptosis in 5RP7 cells. We showed inhibition of cell proliferation that
was time- and dose-dependent in 5RP7 cells for 24 and 48 h. Melatonin was not toxic in NIH/3T3 primary mouse embryonic fibroblast
cells at low doses for 24 and 48 h. The IC50 (380 µM) value of melatonin for 48 h was chosen for advanced assays. The percentages of
early/late apoptotic cells to which melatonin (IC50: 380 µM) was administered were increased 6.2-fold in 5RP7 cells compared to controls
for 48 h. The melatonin treatment resulted in increased caspase-3 activity and reduced the mitochondrial membrane potential in the
5RP7 cells for 48 h. The cell cycle arrest caused by melatonin was observed in G1 and G2 phases in the cell cycle analyses in 5RP7 cells
for 48 h. These findings show that melatonin induces cell death and apoptosis in H-ras oncogene transformed 5RP7 cells. Melatonin may
be an anticancer agent against H-ras oncogene activated cancer cells.
Key words: H-ras oncogene transformed 5RP7 cells, melatonin, apoptosis, caspase-3, cell cycle, mitochondrial membrane potential

1. Introduction
Oncogenes are important factors in the carcinogenesis
process. Cancer cells may demonstrate an uncontrolled
proliferation due to oncogenes. Ras is one of these
oncogenes, and it is responsible for cell differentiation/
proliferation. It is well known that ras mutation occurs
in human tumors such as pancreatic, thyroid, and colon
cancers. H-ras, K-ras, and N-ras proteins belonging to the
ras family play a role in cancer diseases (Brunner et al.,
2004). Thus, ras genes are effective targets for anticancer
drug development (Weiwer et al., 2012). In this study, we
used H-ras oncogene transformed 5RP7 cells. These cells
were obtained from embryonic tissues of Rattus norvegicus
and transformed by the H-ras oncogene.
Melatonin (N-acetyl-5-methoxytryptamine) is a
methoxyindole secretory product as a natural compound,
which is produced by the pineal gland and a variety of
organs (such as the retina, Harderian glands, gut, ovary,
testes, or bone marrow) during the dark phase (LeonBlanco et al., 2003; Sainz et al., 2003; Espesito et al., 2008).
There have been reports published on the pharmacological
effects of melatonin recently. The anticancer and
antioxidant capacities and the preventive effects on cell
aging and the immune system of melatonin have been
* Correspondence: gakalin@anadolu.edu.tr

researched with in vitro and in vivo clinical investigations
(Farriol et al., 2000). Reports have showed that melatonin
decreases cell viability in a large number of cancer cell
models (breast, non-small cell lung, metastatic renal cell
carcinoma, skin, hepatocellular carcinoma, and brain
tumors) (Petranka et al., 1999; Jung and Ahmad, 2006).
There have been numerous reports on the apoptosisinducing effects of melatonin in cancer cells, unlike in the
protection of healthy cells (Sainz et al., 2003; Altun and
Uğur-Altun, 2007; Bejarano et al., 2009).
Apoptosis regulates cell death by controlling the
number and size of the cells (Sainz et al., 2003). Apoptosis
resistance is one of the basic hallmarks in carcinogenesis
(Sainz et al., 2003). The induction of apoptosis is significant
for the development of cancer treatments (Martin-Renedo
et al., 2008). Caspase-3 is a central protein in the triggering
of apoptosis (Joo and Yoo, 2009). Sanchez-Hidalgo et al.
(2012) showed that melatonin induced apoptosis via the
caspase-3 and promoted cell cycle arrest in various cell
lines. Furthermore, it has been observed that melatonin
decreases the mitochondrial membrane potential (Yang et
al., 2006; Yürüker et al., 2015).
The aim of our study was to detect the signal pathways
that underlie the anticancer effects of melatonin against
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H-ras oncogene transformed rat embryo fibroblast 5RP7
cells. We researched the effects of melatonin on apoptosis
using Annexin V/PI, caspase-3 activity, mitochondrial
membrane potential, and the cell cycle arrest assays.
Because the morphological features of apoptosis are
cellular shrinkage, membrane blebbing, chromatin
condensation, and nuclear fragmentation, we also aimed
to study morphological changes induced by melatonin in
5RP7 cells.
2. Materials and methods
2.1. Chemicals
The melatonin was purchased from Sigma Chemical Co.
(St. Louis, MO, USA). Dulbecco’s modified Eagle’s Medium
(DMEM) (Lonza, Switzerland), fetal bovine serum (FBS)
(GIBCO Inc., İstanbul, Turkey), penicillin-streptomycin
(GIBCO Inc.), Dulbecco’s phosphate buffered saline
(PBS) concentrate (10X) (Biological Industries, BeitHaemek, Israel), trypsin/EDTA solution (Biochrom,
Berlin, Germany), 3-(4,5-dimethyl-2-thiazolyl)-2,5diphenyl-2H-tetrazolium bromide (MTT) (Alfa Aesar,
Karlsruhe, Germany), and dimethyl sulfoxide (DMSO)
(Sigma Chemical Co.) were also obtained. The Annexin-V
FITC/propidium iodide (PI) apoptosis detection kits were
purchased from BD Biosciences (San Diego, CA, USA).
The caspase-3 kit was obtained from BD Biosciences. The
JC1 kit was obtained from BD Biosciences. The cell cycle
kits were obtained from BD Biosciences. The Annexin-V
FITC and acridine orange was purchased from Santa Cruz
Biotechnology (Santa Cruz, CA, USA), 4,6-diamidino-2phenylindole (DAPI) was purchased from Sigma Chemical
Co., and Triton X-100 was obtained from Amresco (Solon,
OH, USA).
2.2. Cell culture
The monolayers cultures of the H-ras oncogene
transformed rat embryo fibroblast 5RP7 cells and the
NIH/3T3 primary mouse embryonic fibroblast cells were
obtained from the American Type Culture Collection
(ATCC) (Manassas, VA, USA). The stock cells were
maintained by DMEM supplemented with 10% FBS,
penicillin (100 U/mL), and streptomycin (100 µg/mL) in
a humidified 5% CO2 atmosphere at 37 °C. The cells were
grown in 75 cm2 flasks and subcultured every other day.
For the subculturing, the 5RP7 cells were washed with
PBS and trypsinized. Then the cells were centrifuged and
cultured in new 75 cm2 flasks in DMEM at 37 °C.
2.3. Cytotoxicity of melatonin
To investigate the cytotoxic effects of melatonin, MTT
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium)
analysis was used. The H-ras oncogene transformed rat
embryo fibroblast 5RP7 cells and the NIH/3T3 primary
mouse embryonic fibroblast cells were plated in 96-
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well dishes in DMEM supplemented with 10% FBS and
1% penicillin/streptomycin at a density of 3 × 103 cells/
mL. The melatonin was dissolved in DMSO and diluted
with medium at 1:10. Then the melatonin was added to
each well at defined concentrations ranging from 1 to
1000 µM (this concentration range was determined after
preliminary studies as 1-5-10-25-50-100-125-250-5001000 µM) for 24 and 48 h. After 24 and 48 h of incubation,
MTT dissolved in PBS was added to the cells as 20 µL
and incubated for 2 h. Then the medium was removed
and 100 µL of DMSO was added to each well, dissolving
the sediment. The cells were measured at 540 nm using a
microtiter plate reader (Bio. Tec. ELx808IU, USA). The cell
viability was calculated as a percent ratio and compared
with the control cells.
2.4. Analysis of early/late apoptosis by flow cytometry
The number of apoptotic cells was measured by Annexin
V/PI (propidium iodide) analysis. The 5RP7 cells were
seeded in 6-well plates at a concentration of 1 × 105 cells/
well with DMEM supplemented with 10% FBS and 1%
penicillin-streptomycin. The inhibition concentration of
melatonin (IC50: 380 µM) was added to 5RP7 cells for 48
h. The plates were incubated at 37 °C in an atmosphere
of 5% CO2 for 48 h. After the incubation, the cells were
trypsinized and centrifuged, and the cell pellets were
twice resuspended in PBS. Then 100 µL of binding buffer
solution (0.1 M HEPES/NaOH (pH 7.4), 1.4 M NaCl, 25
mM CaCl2) (BD Pharmingen, San Diego, CA, USA) was
added to each sample, and the cells were stained with
Annexin V-FITC (5 µg/mL) and PI (5 µg/mL) for 15 min
in a dark room temperature (20–25 °C). Then the samples
were analyzed by BD FACSAria Cell Sorter Software
version 6.1.1 flow cytometry. Cells showing early/late
apoptosis were determined as a percentage of all cells.
2.5. Caspase-3 activity by flow cytometry
Caspase-3 activity has a key role and is one of the major
cascade proteins in apoptosis. The H-ras oncogene
transformed 5RP7 cells (100,000) were seeded per sixwell plates. The IC50 (380 µM) inhibition concentration
of melatonin was added to 5RP7 cells at 37 °C in an
atmosphere of 5% CO2 for 48 h. At the end of incubation,
the cells were washed twice with PBS, and the cells were
collected by centrifugation. The cells were suspended in 0.5
mL of BD Cytofix/Cytoperm (aqueous buffered solution
containing paraformaldehyde and saponin) for 20 min at
4 °C. The BD Cytofix/Cytoperm was removed and cells
were washed twice with 0.5 mL of BD Perm/Wash Buffer
(aqueous buffered solution containing saponin, FBS, and
≤0.09% sodium azide). The cells were incubated in 100 µL
of BD Perm/Wash Buffer and 20 µL of caspase-3 antibody
solution (aqueous buffered solution containing BSA and
≤0.09% sodium azide) for 30 min. Then the cells were
washed in 1 mL of BD Perm/Wash Buffer and centrifuged.
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3. Results
3.1. Cytotoxic effects of melatonin on 5RP7 cells
The melatonin showed cytotoxic effects in a time- and
dose-dependent manner on H-ras oncogene transformed
5RP7 cells for 24–48 h when compared with the control
cells (Figure 1A). The increasing concentrations of the
melatonin induced cytotoxicity in the H-ras oncogene
transformed 5RP7 cells (P < 0.05), but the cytotoxic effects
of melatonin were not observed on the NIH/3T3 cells at
low doses (Figure 1B). The cytotoxicity of the melatonin
was less on the NIH/3T3 cells at high doses (250 or 500
µM) for 24–48 h (P > 0.05). However, the highest dose
(1000 µM) of melatonin administered to the NIH/3T3
cells showed more significant reduction (30%–40%) in
viability for 24–48 h (P < 0.05) (Figure 1B). The maximum
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The supernatant was removed and 0.5 mL of BD Perm/
Wash Buffer was added to the cells. Then the samples
were analyzed by BD FACSAria Cell Sorter Software
version 6.1.1 flow cytometry. The cells showing caspase-3
activation were recorded as a percentage of all cells.
2.6. Analysis of mitochondrial membrane potential (JC1)
by flow cytometry
The H-ras oncogene transformed 5RP7 cells were seeded
in six-well plates at a density of 105 cells/mL, and the
IC50 dose of melatonin was added to cells. The cells were
incubated in 5% CO2 air-conditioned atmosphere at 37
°C. After 48 h of incubation, the cells were trypsinized,
washed with PBS, and centrifuged at 400 × g for 5 min.
5’,6,6’-Tetrachloro-1,1’,3,3’-tetraethylbenzimidazolylcarbo
cyanine iodide (JC1) dye solution (1X assay buffer + JC1
stock solution) was added to the cells. The stock solution
was prepared by dissolving the DMSO. Then the samples
were incubated at a temperature of 37 °C for 10–15 min.
After incubation, the cells were washed twice with an
assay buffer and analyzed by BD FACSAria Cell Sorter
Software version 6.1.1 flow cytometry. The cells showing
mitochondrial membrane potential disruption were
determined as a percentage of all cells.
2.7. Analysis of cell cycle by flow cytometry
The percentage of apoptosis and the cells in G0/G1,
G1/M, and S phases was measured. The cells were seeded
at 5 × 105 cells/mL in 6 well-plates and the IC50 dose of
melatonin was added for 48 h. After incubation, the cells
were trypsinized and centrifuged for 400 × g for 5 min
at room temperature. Solution A (trypsin buffer) was
added to each sample and stirred gently by hand. The
samples were incubated with Solution A for 10 min at
room temperature. Then Solution B (trypsin inhibitor and
RNAse buffer) was added and samples were incubated
for 10 min at room temperature. Cold Solution C was
added to the mixture and incubated for 10 min at 4 °C.
The samples were analyzed by BD FACSAria Cell Sorter
Software version 6.1.1 flow cytometry, and the cells in each
cycle were determined as percentages of all cells.
2.8. Confocal microscopy analysis
The 5RP7 cells were plated onto sterilized coverslips in
6-well plates and exposed to the IC50 dose of melatonin
for 48 h at 37 °C. After exposure, the cells were washed
with PBS and stained with Annexin V/FITC and
acridine orange fluorescent dyes. We also stained with
4.6-diamidino-2-phenylindole (DAPI) using a fixative 3.7%
paraformaldehyde. Moreover, 0.2% Triton X-100 was used
for cell membrane permeability. Then the structure of the
cell membrane and nucleus morphologically was observed
and the structural changes were detected. Morphology was
scanned with a Leica TCS-SP5 II confocal microscopy and
Leica Confocal Software version 2.00 was used.
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Figure 1. The time- and dose-dependent effects of melatonin
in H-ras oncogene transformed 5RP7 cells and NIH/3T3 cells
were evaluated by MTT analyses for 24 h and 48 h. A) Melatonin
induced cell death in the H-ras oncogene transformed 5RP7 cells.
B) The toxic effects of the melatonin were not more or less on the
NIH/3T3 cells when compared to the 5RP7 cells. The statistical
significance was detected by one-way ANOVA, followed by
Tukey tests. It was significantly different from the control, *P <
0.05 (n = 6).
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percentages of cell death were 53% for 24 h and 72% for 48
h in the 5RP7 cells. However, the maximum percentages
of NIH/3T3 cell death were 28% for 24 h and 39% for 48
h. The IC50 value of the melatonin was found to be 380
µM in 5RP7 cells for 48 h (Figure 1A). We investigated the
apoptotic effects of melatonin on 5RP7 cells at IC50 (380
µM) concentration. The administration of melatonin (IC50
concentration: 380 µM) to the NIH/3T3 cells did not cause
significant cytotoxicity for either 24 or 48 h (P > 0.05).
3.2. Detection of early/late apoptotic cells via flow
cytometry
After 48 h, the early/late apoptotic cell percentages were
higher in melatonin (380 µM) treated 5RP7 cells compared
to the control cells, as shown in Table 1 and Figure 2. The
early/late apoptotic cells increased 6.2-fold compared to
control cells.
3.3. Melatonin induces caspase-3 activation in 5RP7 cells
The evaluation of caspase-3 activity induced by various
stimuli is a significant subject in apoptosis. To determine
the caspase-dependent apoptosis, we studied the caspase-3
activity in 380 µM melatonin treated 5RP7 cells (Figure 3).
The caspase-3 activity was found to be 17-fold higher in
5RP7 cells compared to the control cells for 48 h (Table 2).
Table 1. Early/late apoptotic effects of melatonin (IC50: 380 µM)
on 5RP7 cells for 48 h. Q1: Necrosis, Q2: late apoptosis, Q3: viability, Q4: early apoptosis.
Groups

Q1

Q2

Q3

Q4

Control (%)

1.7

3.8

93.8

0.6

Melatonin (%)

2.4

1.6

70.2

11.2

3.4. Effects of melatonin on mitochondrial membrane
potential
The 5RP7 cells were treated with melatonin (380 µM),
labeled with JC1 dye, and analyzed by flow cytometry after
48 h (Figure 4). The mitochondrial membrane potential
(ΔΨm) was disrupted 2.5-fold compared to the control
cells for 48 h (Table 3).
3.5. Effects of melatonin on cell cycle
The analysis of the cell cycle check point was performed by
flow cytometry for 48 h and melatonin was found to affect
the cell cycle. The IC50 concentration of melatonin (380
µM) inhibited 5RP7 cell proliferation depending on cell
cycle arrest for 48 h (Table 4). The percentage of the cells
increased in the G0/G1 phase (18% versus the control) for
48 h in 5RP7 cells. A significant decrease in the number of
cells in the S phase (25% versus the control) was detected
and the progressive increase of cell percentage was
observed in the G2/M phase (7% versus control) (Table 4).
These results have showed that apoptosis was associated
with cell cycle arrest in the G0/G1 and G2/M phases in the
H-ras oncogene transformed rat embryo fibroblast 5RP7
cells.
3.6. Morphological evaluation by confocal microscopy
Apoptotic bodies were observed as a result of exposure
of melatonin (IC50: 380 µM) in 5RP7 cells. The cells
stained with Annexin-V/FITC had apoptotic nuclei. The
cytoplasms of the cells were stained with acridine orange.
The morphological changes were nucleus condensation
and DNA fragmentation after Annexin-V FITC/acridine
orange staining. We also used DAPI staining and observed
fragmented nuclei when compared to the untreated cells
in melatonin treated cells (Figure 5).

Figure 2. The quantification of early/late apoptotic cells treated with the indicated concentration of melatonin (IC50: 380 µM) for 48 h by
flow cytometry. The 5RP7 cells were stained with Annexin V/FITC and propidium iodide. Q1: Necrosis, Q2: late apoptosis, Q3: viability,
Q4: early apoptosis. At least 10,000 cells were analyzed per sample, and quadrant analysis was performed.
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Figure 3. Caspase-3 activity after 48 h of inhibition concentration (IC50: 380 µM) of melatonin treatment in 5RP7 cells. Left panel:
Q1+Q3, intact cells; Q2+Q4, exhibiting caspase-3 activity. At least 10,000 cells were analyzed per sample, and quadrant analysis was
performed.
Table 2. Caspase-3 activity of melatonin (IC50: 380 µM) in
5RP7 cells for 48 h. Q1+Q3 = living cells, Q2+Q4 = exhibiting
caspase-3 activity.
Groups

Q1

Q2

Q3

Q4

Control (%)

0.4

0.3

99.3

0.1

Melatonin (%)

5.1

6.2

88.1

0.6

Figure 4. The reduction of the mitochondrial membrane potential in 5RP7 cells by melatonin. The cells treated with the IC50 (380 µM)
dose of melatonin or untreated for 48 h were stained with the mitochondrial-selective JC1 dye and analyzed by flow cytometry. P3:
Mitochondrial membrane polarized cells, P4: mitochondrial membrane depolarized cells. At least 10,000 cells were analyzed per sample,
and quadrant analysis was performed.
Table 3. Effects of melatonin (IC50: 380 µM) on mitochondrial
membrane potential of 5RP7 cells for 48 h.
Groups

P3

P4

Control (%)

96.3

3.8

Melatonin (%)

90.8

9.5
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Table 4. Effects of melatonin (IC50: 380 µM) on the cell cycle of
5RP7 cells for 48 h.
Groups

G0/G1

S

G2/M

Control (%)

42.89

57.11

0.00

Melatonin (%)

60.96

32.17

6.87

The cell cycle analysis of the 5RP7 cells was read by flow
cytometry. The melatonin provided the arrest of the 5RP7 cells
in the G1 phase.

Control

Melatonin

Figure 5. Melatonin induced apoptotic nuclei in H-ras oncogene transformed 5RP7 cells stained with Annexin FITC/acridine orange
and DAPI. Morphologic changes were observed at 48 h of exposure to melatonin (IC50: 380 µM). The apoptotic structures were labeled
with red dye, and the cytoplasm was stained with green dye in the melatonin treatment for Annexin FITC/acridine orange. The nuclei
of the control cells were not stained red. DNA staining with DAPI was observed as a blue color. DAPI identified morphological changes
in nuclei. The arrows show apoptotic bodies.

4. Discussion
The aim of this experiment was to explain the cytotoxic
and apoptotic actions of melatonin in H-ras oncogene
transformed embryo fibroblast 5RP7 cells because
the literature suggests that there are no studies on the
oncostatic effects of melatonin on H-ras oncogene
transformed 5RP7 cells. To detect the apoptotic pathways
activated by melatonin in 5RP7 cells, we analyzed the early/
late apoptotic cell numbers, caspase-3 activity, depolarized
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mitochondrial membrane potential, cell cycle arrest, and
nuclear morphology. Melatonin was administered to
different cell lines and found to have oncostatic effects.
Reports suggest that melatonin treatment reduced
cell growth in MCF7 (human breast carcinoma cell
line) (Liburdy et al., 1993; Furuya et al., 1994; Cos et
al., 1996, 2002; Leon-Blanco et al., 2003; Cucina et al.,
2009; Martinez-Campa et al., 2009; Chottanapund et
al., 2014), BG1 (ovarian carcinoma cell line) (Petranka
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et al., 1999), SK-N-MC (human neuroblastoma cell
line) (Garcia-Santos et al., 2006), B65 (rat dopaminergic
neuroblastoma cell line) (Pizarro et al., 2008), AR42J (rat
pancreatic tumor cell line) (Uguz et al., 2012), HepG2
(hepatocarcinoma cell line) (Martin-Renedo et al., 2008;
Fan et al., 2010), LnCaP (prostate cancer cell line) (Joo
and Yoo, 2009), HL60 (human leukemia cell line), Jurkat
(human T lymphoblastic leukemia cell line), MOLT4 (human T lymphoblastic leukemia cell line), Daudi
(human B lymphoblastic cell line), K562 (erythroleukemia
cell line) (Büyükavcı et al., 2006), SNG-II (human uterine
endometrial adenocarcinoma cell line), and Ishikawa
(human endometrial adenocarcinoma cell line) (Kanishi
et al., 2000) cell lines.
Our results showed that melatonin inhibited cell
viability in 5RP7 cells, and growth inhibition of the
melatonin (380 µM) was both dose- and time-dependent
for 24 and 48 h. However, this cytotoxic effect was not
observed in the NIH/3T3 cells at this concentration. On
the other hand, the reduction in cell viability with the
melatonin was found to be maximal at 1000 µM in both cell
lines. This dose (1000 µM) was much more effective in 5RP7
cells to reduce cell viability. Pizarro et al. (2008) showed
that the same doses of melatonin (0.1 and 1 mM) inhibited
cell proliferation in dopaminergic neuroblastoma B65.
The apoptotic mechanism that melatonin induces has not
been clarified in H-ras oncogene transformed 5RP7 cells.
Apoptotic death is a significant phenomenon for a large
number of diseases, and particularly in cancer. Apoptosis
has some characteristics including both biochemical and
morphological changes. Phosphatidylserine redistribution
is seen from the inner face to the outer face of the cell
membrane in apoptotic cells. This apoptotic pathway
activates proteolytic enzymes called caspases that
mediate the rapid dismantling of cellular organelles and
architecture. Among them, the most important and
well recognized is caspase-3. Caspase-3 is a frequently
activated death protease that catalyzes the specific cleavage
of many key cellular proteins (Akalın Çiftçi et al., 2014).
In our study, percentages of early and late apoptotic cells
caused by phosphatidylserine redistribution in melatonin
(380 µM) treated cells were increased 6.45-fold compared
to control cells (Table 1). Garcia-Santos et al. (2006) also
suggested that the percentage of early/late apoptotic
cells increased by treatment with 1 mM melatonin.
Furthermore, they suggested that caspase-3 activity was
2.5-fold higher than in control cells after 48 h. In our study,
caspase-3 activity was 6.8% in melatonin administered
cells (IC50: 380 µM) and was higher 17-fold compared
to control cells after 48 h. Similar results were obtained
from the studies of Joo and Yoo (2009). They showed that
induction of apoptosis by melatonin in prostate cancer
cells (LNCaP) was observed via early/late apoptosis and

caspase-3 activation. Xu et al. (2013) and Martin-Renedo
et al. (2008) showed the apoptotic effects of melatonin in
SW-1990 (pancreatic cancer) and HepG2 cells respectively
by similar mechanisms. Martin-Renedo et al. (2008) also
showed that treatment with melatonin caused marked
caspase-3 activation in HEPG2 cells (236%–362%).
However, our results showed moderate increases in
caspase-3 activation. These results show that different cells
have different sensitivities to melatonin administration.
Another hallmark of apoptosis is identifying the changes
in the mitochondrial membrane potential. In a previous
study, melatonin reduced the mitochondrial membrane
potential (Fischer et al., 2008). In our study, melatonin
also disrupted the mitochondrial membrane potential in
the 5RP7 cells, showing a triggering of the mitochondrial
apoptotic pathway.
In our study we also investigated cell cycle arrest in
melatonin treated 5RP7 cells because caspases, which are
activated to trigger apoptosis, affect cell cycle regulation
and signaling pathways together with the morphological
manifestations of apoptosis, such as DNA condensation
and fragmentation and membrane blebbing (Mancini et
al., 1998). The percentage of cells were increased in G1
and G2 phases in comparison with control cells, but the
percentages of cells in the S phase decreased. Cos et al.
(1996) suggested that melatonin increased the duration
of cell cycle arrest of human breast cancer cells at the
G0/G1 phase. In another study, melatonin increased the
percentage of cells in the G1 phase of the cell cycle in
B65 cells (Pizarro et al., 2008). The growth inhibition of
melatonin appeared in the G0-G1 and G2-M phases in
HepG2 cells (Martin-Renedo et al., 2008). Melatonin
accumulated in human neuroblastoma cells in the G2/M
cell cycle phase (Garcia-Santos et al., 2006). Hong et
al. (2014) showed that melatonin blocked the S phase
percentage of the cells at 48 h and induced G1 phase arrest.
These differences may be attributed to doses of melatonin
used in the treatment of cells or to the types of cells.
Because apoptosis is morphologically characterized by
cytoplasmic contraction, chromatin condensation, plasma
membrane blebbing, and DNA fragmentation (Sainz et
al., 2003), we also made microscopic evaluations. Our
results showed that the apoptotic effects of the melatonin
were nuclear condensation and DNA fragmentation
in the H-ras oncogene transformed 5RP7 cells. Similar
results were obtained from different studies. GarciaSantos et al. (2006) showed condensed and fragmented
nuclei by DNA staining with DAPI in SK-N-MC human
neuroblastoma cells to which 1 mM melatonin was
administered. Apoptotic bodies of SK-LU-1 human lung
adenocarcinoma after treatment with melatonin (1 mM
and 2 mM) were also detected by DAPI staining (Plaimee
et al., 2015).
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All of these assessments suggest that melatonin has
oncostatic and antiproliferative effects against 5RP7 cells.
These effects are dose- and time-dependent. Furthermore,
melatonin caused apoptotic effects in this H-ras oncogene
transformed cells. The most likely mechanisms of action

are the arrest of cell cycle and the induction of apoptosis
by caspase-3 activation, with decreased mitochondrial
membrane potential. This study suggests that melatonin
may be a useful pharmacological inhibitor agent against
H-ras oncogene activated cancer cells.
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